Skip to main content
Top
Published in: Diabetologia 3/2023

16-12-2022 | Editorial

The changing landscape of scientific communication at EASD

Authors: Chantal Mathieu, Eleanor Kennedy, Patrick Schrauwen, Hindrik Mulder

Published in: Diabetologia | Issue 3/2023

Login to get access

Excerpt

The saying ‘truth is stranger than fiction’ very much applies to scientific research and how it is communicated today. Twenty years ago, who would have foreseen that most scientific journals would no longer be printed; that we would read scientific articles on a little computer small enough to fit in our pockets; that scientific conferences could be held virtually, with nobody physically present on site; and that education would become a global effort through e-Learning platforms? All these changes are great opportunities, but they also present major challenges. Therefore, what are EASD and its journal, Diabetologia, doing to keep abreast of the situation? …
Metadata
Title
The changing landscape of scientific communication at EASD
Authors
Chantal Mathieu
Eleanor Kennedy
Patrick Schrauwen
Hindrik Mulder
Publication date
16-12-2022
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2023
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-022-05850-y

Other articles of this Issue 3/2023

Diabetologia 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.